Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Low-interventional Study to Evaluate Long-term Effectiveness of Real-world Prophylactic Treatment With Efanesoctocog Alfa on Joint Health in People With Haemophilia A (ALTITUDE)

NCT06940830 is registered in ClinicalTrials.gov with Swedish Orphan Biovitrum as lead sponsor.

NCT NCT06940830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06940830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Low-interventional Study to Evaluate Long-term Effectiveness of Real-world Prophylactic Treatment With Efanesoctocog Alfa on Joint Health in People With Haemophilia A (ALTITUDE)
Lead sponsor
Swedish Orphan Biovitrum
Phase
Phase 4
Overall status
Active, not recruiting
Start date
May 21, 2025
Completion date
December 31, 2028
Enrollment
252 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a